Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin

INTRODUCTION: A significant decrease in red blood cell (RBC) survival has been observed in patients with renal failure, which is supposed to contribute to renal anemia. The aim of this observational study was to determine RBC survival in hemodialysis (HD) patients treated with roxadustat or recombin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaowei, Zhao, Bing, Wang, Jing, Wang, Lei, Tao, Min, Lu, Jing, Lin, Jiangong, Sun, Jing, Wang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525968/
https://www.ncbi.nlm.nih.gov/pubmed/34657570
http://dx.doi.org/10.1080/0886022X.2021.1988968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525968/
https://www.ncbi.nlm.nih.gov/pubmed/34657570
http://dx.doi.org/10.1080/0886022X.2021.1988968

Ejemplares similares